The global healthcare BPO market size accounted for USD 427.32 billion in 2024, grew to USD 466.64 billion in 2025 and is predicted to surpass around USD 1030.34 billion by 2034, representing a healthy CAGR of 9.20% between 2024 and 2034. The North America healthcare BPO market size is calculated at USD 209.39 billion in 2024 and is expected to grow at a fastest CAGR of 9.30% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Healthcare BPO Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Healthcare BPO Market, by Provider Service, 2023 to 203
2
8.1.1 Revenue Cycle Management
8.1.1.1. Market Revenue and Forecast (A)
8.1.2. Patient Enrolments
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Patient Care
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Healthcare BPO Market, by Payer Service, 2024-2034
9.1.1. Claims Management
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Product Development & Business Acquisition (PDBA)
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Member Management
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Provider Management
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Care Management
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Integrated Front-End Services and Back-office Operations
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.7. Billing and accounts management services
9.1.8.1. Market Revenue and Forecast (2021-2034)
9.1.8. HR Services
9.1.8.1. Market Revenue and Forecast (2021-2034)
10.1. Healthcare BPO Market, by Life Science Service, 2024-2034
10.1.1. Manufacturing
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. R&D
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Non-Clinical Services
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.1.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.1.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.2.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.2.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.3.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.3.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.4.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.4.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.5.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.5.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Provider Service (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Payer Service (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Life Science Service (2021-2034)
12.1. Accenture (Ireland)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Access Healthcare (US)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Akurate Management Solutions (US)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cognizant (US)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Firstsource Solutions (India)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. GeBBS Healthcare Solutions (US)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Genpact (US)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. HCL Technologies (India)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. IBM Corporation (US)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Infosys BPM (India)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample